![](https://i0.wp.com/hrnxt.com/wp-content/uploads/2021/01/Acquisition.jpg?resize=200%2C112&ssl=1)
Dr. Reddy’s Laboratories SA, wholly-owned subsidiary of Dr. Reddy’s Laboratories Ltd., along with its subsidiaries together referred to as “Dr. Reddy’s”) announced that it has entered into a definitive agreement to acquire the U.S. generic prescription product portfolio of Salisbury, Australia, based Mayne Pharma Group Limited. The portfolio includes approximately 45 commercial products, four pipeline…